$AZTA
Azenta Inc

2021 Q4 Form 10-Q Financial Statement

#000155837022000952 Filed on February 09, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $139.7M $136.9M $118.1M
YoY Change 18.21% 26.51% 28.85%
Cost Of Revenue $72.61M $269.9M $60.81M
YoY Change 19.41% 24.73% -51.55%
Gross Profit $67.04M $66.14M $57.34M
YoY Change 16.93% 25.9% 48.21%
Gross Profit Margin 48.01% 48.3% 48.53%
Selling, General & Admin $60.71M $231.4M $51.93M
YoY Change 16.91% 21.63% -12.49%
% of Gross Profit 90.55% 349.85% 90.57%
Research & Development $6.485M $22.41M $5.088M
YoY Change 27.46% 25.78% -64.67%
% of Gross Profit 9.67% 33.88% 8.87%
Depreciation & Amortization $12.88M $16.65M $15.75M
YoY Change -18.18% -74.58% -4.57%
% of Gross Profit 19.22% 25.17% 27.46%
Operating Expenses $67.37M $253.8M $56.98M
YoY Change 18.23% 21.98% -23.33%
Operating Profit -$325.0K -$21.24M $356.0K
YoY Change -191.29% 1436.98% -102.96%
Interest Expense $455.0K -$1.405M $557.0K
YoY Change -18.31% -32.94% -24.42%
% of Operating Profit 156.46%
Other Income/Expense, Net -$1.077M -$16.48M $1.281M
YoY Change -184.07% 931.62% -407.19%
Pretax Income -$1.822M -$48.97M $1.156M
YoY Change -257.61% 21.54% -88.68%
Income Tax -$4.700M -$20.10M -$1.600M
% Of Pretax Income -138.41%
Net Earnings $43.32M $21.81M $26.03M
YoY Change 66.44% -24.74% 99.34%
Net Earnings / Revenue 31.02% 15.92% 22.03%
Basic Earnings Per Share $0.58 $0.29 $0.35
Diluted Earnings Per Share $0.58 $0.29 $0.35
COMMON SHARES
Basic Shares Outstanding 74.63M 74.30M 74.02M
Diluted Shares Outstanding 74.87M 74.28M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.2M $227.5M $263.6M
YoY Change -18.35% -9.25% -23.94%
Cash & Equivalents $215.2M $227.4M $263.5M
Short-Term Investments $51.00K $81.00K $55.00K
Other Short-Term Assets $371.6M $354.3M $33.09M
YoY Change 1022.96% 40.57% 12.16%
Inventory $70.14M $60.40M $123.9M
Prepaid Expenses
Receivables $126.0M $119.9M $196.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $796.7M $777.4M $675.2M
YoY Change 18.01% 19.7% 1.76%
LONG-TERM ASSETS
Property, Plant & Equipment $195.2M $180.4M $169.1M
YoY Change 15.47% 60.96% 60.57%
Goodwill $468.6M $469.4M $513.0M
YoY Change -8.66% 3.57% 4.61%
Intangibles
YoY Change
Long-Term Investments $3.724M $3.598M $3.410M
YoY Change 9.21% 16.03% 13.67%
Other Assets $60.04M $58.07M $71.60M
YoY Change -16.14% 16.64% 47.53%
Total Long-Term Assets $1.058B $1.042B $939.6M
YoY Change 12.63% 14.55% 4.92%
TOTAL ASSETS
Total Short-Term Assets $796.7M $777.4M $675.2M
Total Long-Term Assets $1.058B $1.042B $939.6M
Total Assets $1.855B $1.820B $1.615B
YoY Change 14.88% 16.69% 3.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $46.87M $42.36M $67.81M
YoY Change -30.88% 64.9% 3.84%
Accrued Expenses $131.5M $139.0M $104.9M
YoY Change 25.36% 90.71% 21.82%
Deferred Revenue $28.48M $25.72M $35.66M
YoY Change -20.13% -0.2% 22.79%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $171.0K $360.0K $414.0K
YoY Change -58.7% -56.47% -49.94%
Total Short-Term Liabilities $341.8M $345.1M $225.8M
YoY Change 51.39% 63.46% -20.21%
LONG-TERM LIABILITIES
Long-Term Debt $49.70M $49.68M $49.63M
YoY Change 0.15% 0.18% -0.58%
Other Long-Term Liabilities $4.372M $6.173M $11.68M
YoY Change -62.55% 374.12% 25.66%
Total Long-Term Liabilities $54.07M $55.85M $61.30M
YoY Change -11.79% 9.75% 3.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $341.8M $345.1M $225.8M
Total Long-Term Liabilities $54.07M $55.85M $61.30M
Total Liabilities $487.5M $494.2M $362.6M
YoY Change 34.46% 42.97% -9.42%
SHAREHOLDERS EQUITY
Retained Earnings -$434.2M -$470.1M -$532.5M
YoY Change -18.45% -14.7% -8.31%
Common Stock $1.978B $1.977B $1.950B
YoY Change 1.44% 1.71% 1.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $13.46M $13.46M $13.46M
Shareholders Equity $1.367B $1.325B $1.252B
YoY Change
Total Liabilities & Shareholders Equity $1.855B $1.820B $1.615B
YoY Change 14.88% 16.69% 3.58%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income $43.32M $21.81M $26.03M
YoY Change 66.44% -24.74% 99.34%
Depreciation, Depletion And Amortization $12.88M $16.65M $15.75M
YoY Change -18.18% -74.58% -4.57%
Cash From Operating Activities $15.62M $27.11M $43.73M
YoY Change -64.29% -28.4% 69.87%
INVESTING ACTIVITIES
Capital Expenditures $18.41M -$18.20M $15.23M
YoY Change 20.9% -54.42% 58.38%
Acquisitions $15.06M
YoY Change
Other Investing Activities -$16.00K $683.0K -$15.07M
YoY Change -99.89% -96.02% -166.07%
Cash From Investing Activities -$18.43M -$17.52M -$30.29M
YoY Change -39.18% -22.98% -329.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.680M -4.458M -8.157M
YoY Change -5.85% -83.5% 0.68%
NET CHANGE
Cash From Operating Activities 15.62M 27.11M 43.73M
Cash From Investing Activities -18.43M -17.52M -30.29M
Cash From Financing Activities -7.680M -4.458M -8.157M
Net Change In Cash -12.29M 5.138M 16.53M
YoY Change -174.35% -143.18% -50.91%
FREE CASH FLOW
Cash From Operating Activities $15.62M $27.11M $43.73M
Capital Expenditures $18.41M -$18.20M $15.23M
Free Cash Flow -$2.791M $45.31M $28.50M
YoY Change -109.79% -41.75% 76.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PrepaidExpenseAndOtherAssetsCurrent
CY2021Q4 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
43320000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26028000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.azenta.com/20211231#AccruedExpensesAndOtherCurrentLiabilities
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.azenta.com/20211231#AccruedExpensesAndOtherCurrentLiabilities
CY2020Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Restricted Cash Current Asset Statement Of Financial Position Extensible List
RestrictedCashCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PrepaidExpenseAndOtherAssetsCurrent
CY2020Q4 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.azenta.com/20211231#AccruedExpensesAndOtherCurrentLiabilities
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.azenta.com/20211231#AccruedExpensesAndOtherCurrentLiabilities
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000933974
CY2021Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
000-25434
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
AZENTA, INC.
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3040660
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
15 Elizabeth Drive
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Chelmsford
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01824
CY2021Q4 dei City Area Code
CityAreaCode
978
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
262-2400
CY2021Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2021Q4 dei Trading Symbol
TradingSymbol
AZTA
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.01
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74915975
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
215168000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227427000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
51000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
81000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126001000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119877000
CY2021Q4 us-gaap Inventory Net
InventoryNet
70143000
CY2021Q3 us-gaap Inventory Net
InventoryNet
60398000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
60833000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58198000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
324533000
CY2021Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
311385000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
796729000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
777366000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
147261000
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
130719000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
3724000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
3598000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13845000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10043000
CY2021Q4 us-gaap Goodwill
Goodwill
468585000
CY2021Q3 us-gaap Goodwill
Goodwill
469356000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178589000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
186534000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60042000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58068000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
186162000
CY2021Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
183828000
CY2021Q4 us-gaap Assets
Assets
1854937000
CY2021Q3 us-gaap Assets
Assets
1819512000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
46869000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
42360000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28483000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
25724000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2342000
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2330000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24872000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33183000
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
142000
CY2021Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
304000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
14037000
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8711000
CY2021Q4 azta Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
104306000
CY2021Q3 azta Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
103537000
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
120749000
CY2021Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
128939000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
341800000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
345088000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49702000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49677000
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1995000
CY2021Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1973000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
13141000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
13030000
CY2021Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
726000
CY2021Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
705000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43802000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45088000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4372000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6173000
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
31976000
CY2021Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
32444000
CY2021Q4 us-gaap Liabilities
Liabilities
487514000
CY2021Q3 us-gaap Liabilities
Liabilities
494178000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88375410
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74913541
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87808922
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74347053
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
884000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
878000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1977571000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1976112000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
24149000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19351000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
13461869
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
13461869
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
200956000
CY2021Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
200956000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-434225000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-470051000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1367423000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1325334000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1854937000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1819512000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139652000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118142000
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
72608000
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
60807000
CY2021Q4 us-gaap Gross Profit
GrossProfit
67044000
CY2020Q4 us-gaap Gross Profit
GrossProfit
57335000
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6485000
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5088000
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60711000
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51930000
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
173000
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
-40000
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
67369000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
56979000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-325000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
356000
CY2021Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
35000
CY2020Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
76000
CY2021Q4 us-gaap Interest Expense
InterestExpense
455000
CY2020Q4 us-gaap Interest Expense
InterestExpense
557000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1077000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1281000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1822000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1156000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4680000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1550000
CY2021Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2858000
CY2020Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2706000
CY2021Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
40462000
CY2020Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
23322000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
43320000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
26028000
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.54
CY2020Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.32
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.54
CY2020Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.31
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74630000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74021000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74866000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74283000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
43320000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
26028000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4801000
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13264000
CY2021Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
0
CY2020Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-5000
CY2021Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-3000
CY2020Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-38000
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4798000
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
13226000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48118000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39254000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
43320000
CY2020Q4 us-gaap Profit Loss
ProfitLoss
26028000
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12883000
CY2020Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15746000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
7891000
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
6710000
CY2021Q4 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-56000
CY2020Q4 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-56000
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3084000
CY2020Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4960000
CY2021Q4 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
95000
CY2020Q4 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-1000
CY2020Q4 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-948000
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1121000
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4504000
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32150000
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6307000
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19647000
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28945000
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2219000
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5727000
CY2021Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4056000
CY2020Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3186000
CY2021Q4 azta Increase Decrease In Accrued Warranty And Retrofit Costs
IncreaseDecreaseInAccruedWarrantyAndRetrofitCosts
-103000
CY2020Q4 azta Increase Decrease In Accrued Warranty And Retrofit Costs
IncreaseDecreaseInAccruedWarrantyAndRetrofitCosts
-185000
CY2021Q4 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-5371000
CY2020Q4 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-12307000
CY2021Q4 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-154000
CY2020Q4 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-75000
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
9114000
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-15279000
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15618000
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43730000
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18409000
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15227000
CY2021Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
46000
CY2020Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4000
CY2021Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
30000
CY2020Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15061000
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18425000
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30292000
CY2021Q4 azta Repayments Of Finance Leases
RepaymentsOfFinanceLeases
186000
CY2020Q4 azta Repayments Of Finance Leases
RepaymentsOfFinanceLeases
319000
CY2020Q4 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
414000
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7494000
CY2020Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7424000
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7680000
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8157000
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1804000
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11250000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12291000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16531000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
285333000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
302526000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
273042000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
319057000
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
333000
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
370000
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10911000
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3697000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
215168000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
263517000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
45000000
CY2020Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
45000000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3568000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3571000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
9306000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6969000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
273042000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
319057000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1325334000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1465000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2021Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7494000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
4801000
CY2021Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
0
CY2021Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-3000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
43320000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1367423000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1213614000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6710000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2020Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7424000
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
13264000
CY2020Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-5000
CY2020Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-38000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
26028000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1252154000
CY2021Q4 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">1. Nature of Operation </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Azenta, Inc. (“Azenta”, or the “Company”) is a leading global provider of life science sample exploration and management solutions for the life sciences market. The Company supports its customers from research to clinical development with its sample management, automated storage, and genomic services expertise to help bring impactful therapies to market faster.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Discontinued Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the fourth quarter of fiscal year 2021, the Company entered into a definitive agreement to sell its semiconductor automation business to Thomas H. Lee Partners, L.P. (“THL”). The Company determined that the semiconductor automation business met the “held for sale” criteria and the “discontinued operations” criteria in accordance with Financial Accounting Standard Boards (“FASB”) Accounting Standards Codification (“ASC”) 205, <i style="font-style:italic;">Presentation of Financial Statements</i>, (“FASB ASC 205”) as of September 30, 2021. Results related to the semiconductor automation business are included within discontinued operations. Please refer to Note 3, “Discontinued Operations” for further information about the discontinued businesses. The Consolidated Balance Sheets and Consolidated Statements of Operations, and the notes to the Consolidated Financial Statements were restated for all periods presented to reflect the discontinuation of the semiconductor automation business in accordance with FASB ASC 205. The discussion in the notes to these Consolidated Financial Statements, unless otherwise noted, relate solely to the Company's continuing operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 1, 2022, subsequent to the close of our first fiscal quarter of 2022, the Company completed the sale of the semiconductor automation business for $3.0 billion in cash, subject to working capital and other customary adjustments. The Company expects net cash proceeds from the sale to be approximately $2.4 billion, after adjustments and deducting taxes and other items.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risks and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#212529;white-space:pre-wrap;">The Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial market conditions, fluctuations in customer demand, acceptance of new products, development by its </span>competitors<span style="color:#212529;white-space:pre-wrap;"> of new technological innovations, risk of disruption in its supply chain, the implementation of tariffs and export controls, dependence on key personnel, protection of proprietary technology, and compliance with domestic and foreign regulatory authorities and agencies. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="color:#212529;white-space:pre-wrap;"> During the COVID-19 pandemic, the Company’s facilities have remained operational with only required personnel on site, and the balance of employees working from home.  The Company’s business falls within the classification of an “Essential Critical Infrastructure Sector” as defined by the U.S. Department of Homeland Security and the Company has continued operations during the COVID-19 pandemic. The Company has followed government guidance in each region and has implemented the U.S. Centers for Disease Control and Prevention social distancing guidelines and other best practices to protect the health and safety of the Company’s employees. The COVID-19 pandemic has not had a substantial negative impact on the Company’s financial results and a portion of this impact has been mitigated by the Company’s realignment of resources to satisfy incremental orders related to virus research and vaccine development and commercialization. Future impacts </span><span style="color:#212529;background:#ffffff;">on the Company’s financial results are not fully determinable, as the full impact of the pandemic on the economy and markets which the Company serves is as yet unknown, but will be dependent, in part, on future variants of the virus and vaccine effectiveness against these variants and new or prolonged government responses to the pandemic. The Company’s financial results will also depend on variables including reduced demand from its customers, the degree that the supply chain may be constrained which could impact its delivery of product and the potential impact to its operations if there is a significant outbreak among the Company’s employees, as well as the amount of incremental demand caused by research and treatments in the areas of COVID-19 or related threats</span><span style="color:#212529;white-space:pre-wrap;">. </span></p>
CY2021Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of unaudited consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates are associated with recording accounts receivable, inventories, goodwill, intangible assets other than goodwill, long-lived assets, derivative financial instruments, deferred income taxes, warranty obligations, revenue recognized in accordance with the percentage of completion method, and stock-based compensation expense. The Company assesses the estimates on an ongoing basis and record changes in estimates in the period they occur and become known. Actual results could differ from these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, including results of operations and financial condition, sales, expenses, reserves and allowances, manufacturing and employee-related amounts, will depend on future developments that are highly uncertain. This includes results from new information that may emerge concerning COVID-19 and any actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. The Company has made estimates of the impact of COVID-19 within its financial statements and there may be changes to those estimates in future periods.</p>
CY2021Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1900000
CY2020Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-800000
CY2021Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-70000
CY2020Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1162000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
3774000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3774000
CY2021Q3 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
3679000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3679000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
46000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
51000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
3677000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3774000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2021Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-800000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
331715000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
153126000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178589000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
331606000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
145072000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
186534000
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8000000.0
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8900000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
24099000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
30845000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
27354000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
22574000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
19435000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
54282000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178589000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
50000000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50000000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
298000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
49702000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49702000
CY2021Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
2171000
CY2020Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
1704000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
75000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
311000
CY2021Q4 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000
CY2020Q4 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
16000
CY2021Q4 azta Finance Lease Cost
FinanceLeaseCost
78000
CY2020Q4 azta Finance Lease Cost
FinanceLeaseCost
327000
CY2021Q4 us-gaap Variable Lease Cost
VariableLeaseCost
518000
CY2020Q4 us-gaap Variable Lease Cost
VariableLeaseCost
406000
CY2021Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
354000
CY2020Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
38000
CY2021Q4 us-gaap Lease Cost
LeaseCost
3121000
CY2020Q4 us-gaap Lease Cost
LeaseCost
2475000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
47971000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49650000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5342000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5254000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43802000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45088000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
49144000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
50342000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
2252000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
2252000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
2180000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
2105000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
72000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
147000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
171000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
360000
CY2021Q4 azta Finance Lease Liability Noncurrent Net
FinanceLeaseLiabilityNoncurrentNet
-10000
CY2021Q3 azta Finance Lease Liability Noncurrent Net
FinanceLeaseLiabilityNoncurrentNet
-10000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
161000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
350000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y2M4D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y3M29D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y3M29D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M10D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0389
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0390
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0486
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0487
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1659000
CY2020Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1432000
CY2021Q4 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000
CY2020Q4 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
16000
CY2021Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
190000
CY2020Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
304000
CY2021Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
186000
CY2020Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3532000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5428000
CY2021Q4 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
171000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6479000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5769000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5578000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5499000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5298000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
27574000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
61625000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
171000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12481000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
10000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
49144000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
161000
CY2021Q4 azta Lease Liability Payments Due Leases Not Commenced With Future Lease Payments Excluding Purchase Options
LeaseLiabilityPaymentsDueLeasesNotCommencedWithFutureLeasePaymentsExcludingPurchaseOptions
4500000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000
CY2021Q4 azta Income Tax Expense Benefit Increase Decrease Stock Compensation Discrete Expense Benefit
IncomeTaxExpenseBenefitIncreaseDecreaseStockCompensationDiscreteExpenseBenefit
-4800000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1600000
CY2020Q4 azta Income Tax Expense Benefit Increase Decrease Stock Compensation Discrete Expense Benefit
IncomeTaxExpenseBenefitIncreaseDecreaseStockCompensationDiscreteExpenseBenefit
-1900000
CY2021Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
400000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
130415000
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
124195000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4414000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4318000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126001000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119877000
CY2021Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
34379000
CY2021Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
27644000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1835000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4787000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
33929000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27967000
CY2021Q4 us-gaap Inventory Net
InventoryNet
70143000
CY2021Q3 us-gaap Inventory Net
InventoryNet
60398000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4600000
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3700000
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
23200000
CY2021Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
22700000
CY2021Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
600000
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2330000
CY2021Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
660000
CY2021Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
673000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2342000
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2211000
CY2020Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
648000
CY2020Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
592000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2267000
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7891000
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6710000
CY2021Q4 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Financial Metric Target Met
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedFinancialMetricTargetMet
1
CY2020 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Financial Metric Target Met
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedFinancialMetricTargetMet
1
CY2021 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Financial Metric Target Met
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedFinancialMetricTargetMet
1
CY2021Q4 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Financial Metric Maximum Threshold Met
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedFinancialMetricMaximumThresholdMet
2
CY2020 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Financial Metric Maximum Threshold Met
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedFinancialMetricMaximumThresholdMet
2
CY2021 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Financial Metric Maximum Threshold Met
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedFinancialMetricMaximumThresholdMet
2
CY2021Q4 azta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Performance Based Units Awarded Measurement Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceBasedUnitsAwardedMeasurementPeriod
P3Y
CY2020Q4 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2021Q4 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2021Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2858000
CY2020Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2706000
CY2021Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
40462000
CY2020Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
23322000
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
43320000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26028000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74630000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74021000
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
236000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
262000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74866000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74283000
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.54
CY2020Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.32
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.54
CY2020Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.31
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2020Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139652000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118142000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126000000.0
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119900000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
18800000
CY2021Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
15300000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
28500000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
25700000
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
13800000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
53400000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
37409000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15971000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
53380000
CY2021Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P60M
CY2020Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2020Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2020Q4 azta Number Of Reportable Segments Previously Operated
NumberOfReportableSegmentsPreviouslyOperated
3
CY2021Q4 azta Number Of Reportable Segments Previously Operated
NumberOfReportableSegmentsPreviouslyOperated
3
CY2020Q4 azta Number Of Reportable Segments Previously Operated
NumberOfReportableSegmentsPreviouslyOperated
3
CY2021Q4 azta Number Of Reportable Segments Previously Operated
NumberOfReportableSegmentsPreviouslyOperated
3
CY2021Q4 us-gaap Restructuring Charges
RestructuringCharges
173000
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
-40000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-325000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
356000
CY2021Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
35000
CY2020Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
76000
CY2021Q4 us-gaap Interest Expense
InterestExpense
455000
CY2020Q4 us-gaap Interest Expense
InterestExpense
557000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1077000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1281000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1822000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1156000
CY2021Q4 azta Cash And Cash Equivalents Restricted Cash And Marketable Securities
CashAndCashEquivalentsRestrictedCashAndMarketableSecurities
231817000
CY2021Q3 azta Cash And Cash Equivalents Restricted Cash And Marketable Securities
CashAndCashEquivalentsRestrictedCashAndMarketableSecurities
244012000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13845000
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10043000
CY2021Q4 us-gaap Other Assets
OtherAssets
15019000
CY2021Q3 us-gaap Other Assets
OtherAssets
11237000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
510695000
CY2021Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
495213000
CY2021Q4 us-gaap Assets
Assets
1854937000
CY2021Q3 us-gaap Assets
Assets
1819512000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139652000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118142000
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1300000

Files In Submission

Name View Source Status
0001558370-22-000952-index-headers.html Edgar Link pending
0001558370-22-000952-index.html Edgar Link pending
0001558370-22-000952.txt Edgar Link pending
0001558370-22-000952-xbrl.zip Edgar Link pending
azta-20211231.xsd Edgar Link pending
azta-20211231x10q.htm Edgar Link pending
azta-20211231x10q_htm.xml Edgar Link completed
azta-20211231xex31d1.htm Edgar Link pending
azta-20211231xex31d2.htm Edgar Link pending
azta-20211231xex32.htm Edgar Link pending
azta-20211231_cal.xml Edgar Link unprocessable
azta-20211231_def.xml Edgar Link unprocessable
azta-20211231_lab.xml Edgar Link unprocessable
azta-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending